(NP (NP (NP (NN Regulation)) (PP (IN of) (NP (NP (NN glucocorticoid) (NNS receptors)) (PP (IN in) (NP (JJ human) (JJ mononuclear) (NNS cells))))) (: :)) (NP (NP (NP (NNS effects)) (PP (IN of) (NP (NN glucocorticoid) (NN treatment)))) (, ,) (NP-COOD (NP (NP (NN Cushing) (POS 's)) (NN disease)) (CC and) (NP (NN ketoconazole))) (. .)))
(S (NP-SBJ-31 (NP (NN Glucocorticoid) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NN GcR)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN determined) (NP (-NONE- *-31)) (PP (IN by) (NP (NP (DT a) (JJ whole) (NN cell) (NN assay)) (PP (IN in) (NP (NP (NP (JJ human) (JJ mononulear) (NNS leukocytes)) (PRN (-LRB- -LRB-) (NP (NN hMNL)) (-RRB- -RRB-))) (PP (IN from) (NP-COOD (NP (NN control) (NNS subjects)) (, ,) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN glucocorticoid) (NN therapy)) (PP (IN for) (NP (JJ systemic) (NNS diseases)))))) (CC and) (NP (NP (NP (NP (NN Cushing) (POS 's)) (NN disease)) (NNS patients)) (PP (PP-COOD (PP (IN with) (NP (-NONE- *RNR*-32))) (CC or) (PP (IN without) (NP (-NONE- *RNR*-32)))) (NP-32 (NN ketoconazole) (NN therapy)))))))))))) (. .))
(S (NP-SBJ (JJ Prolonged) (NN corticosteroid) (NN treatment)) (VP (VBD resulted) (PP (IN in) (NP (NP (NN down-regulation)) (PP (IN of) (NP (NN GcR))))) (, ,) (SBAR (IN while) (S (NP (NP (DT the) (NN mean) (NN level)) (PP (IN of) (NP (NN GcR))) (PP (IN in) (NP (NP (NN Cushing) (POS 's)) (NN disease)))) (VP (VBD was) (ADJP-PRD (JJ normal)))))) (. .))
(S (PP (IN In) (NP (DT this) (NN group))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ-COOD (NP (NN receptor) (NNS levels)) (CC and) (NP (NN morning) (NN plasma) (NN cortisol) (NNS values))) (VP (VBD showed) (NP (DT a) (JJ negative) (NN correlation)) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG indicating) (NP (DT a) (JJ subtle) (JJ down-regulatory) (NN effect))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NN GcR)) (VP (VBD were) (ADJP-PRD (JJ unaltered)) (SBAR-TMP (IN after) (S (NP-SBJ (DT these) (NNS patients)) (VP (VBD received) (NP (NN ketoconazole))))) (, ,) (PP (IN in) (NN spite) (IN of) (NP (NP (DT a) (JJ marked) (NN reduction)) (PP (IN in) (NP-COOD (NP (NN morning) (NN plasma) (NN cortisol)) (CC and) (NP (ADJP (JJ urinary) (JJ free)) (NN cortisol))))))) (. .))
(S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD observed) (SBAR (IN that) (S (NP-SBJ (NN ketoconazole)) (VP (VBD was) (NP-PRD (NP (DT a) (JJ weak) (NN competitor)) (PP (IN of) (NP (NN GcR)))) (PP (IN in) (NP (JJ intact) (NNS cells))) (, ,) (SBAR (IN although) (S (NP-SBJ (PRP it)) (ADVP (RB significantly)) (VP (VBD inhibited) (NP (NN -LCB-3H-RCB-) (NN dexamethasone) (NN binding)) (PP (IN in) (NP (NP (JJ cytosolic) (NNS preparations)) (PP (IN from) (NP (NN rat) (NNS tissues)))))))))))) (. .))
(S (NP-SBJ (DT The) (NNS results)) (VP (VBD suggested) (SBAR (IN that) (S-COOD (S (NP-SBJ-33 (NP (NN GcR)) (PP (IN in) (NP (NN hMNL)))) (VP (VBP are) (VP (VBN down-regulated) (NP (-NONE- *-33)) (PP (IN by) (NP (NP (JJ synthetic) (NNS steroids)) (VP (VBN given) (NP (-NONE- *)) (ADVP (FW in) (FW vivo)))))))) (, ,) (CC but) (S (NP-SBJ (PRP they)) (VP (VBD showed) (NP (ADJP (RB very) (JJ mild)) (NN down-regulation)) (PP (IN in) (NP (NP (JJ hypercortisolemic) (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NP (NN Cushing) (POS 's)) (NN disease))))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP-SBJ (PRP we)) (VP (VBD did) (RB not) (VP (VBN observed) (NP (NP-COOD (CC either) (NP (NN up-regulation)) (CC or) (NP (NN antagonism))) (PP (IN of) (NP (NN GcR))) (PP (IN by) (NP (NN ketoconazole) (NN treatment)))) (, ,) (PP-TMP (IN at) (NP (NP (DT the) (NN time)) (SBAR (WHADVP-36 (IN that)) (S (NP-SBJ-37 (NP (NN cortisol) (NNS levels)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN Cushing) (POS 's)) (NN disease)))))) (VP (VBD were) (VP (VBN reduced) (NP (-NONE- *-37)) (ADVP (-NONE- *T*-36)))))))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ indicates) (SBAR-COOD (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN in) (NP (NP (NN Cushing) (POS 's)) (NN disease)))) (VP (VBP are) (PP-PRD (JJ due) (PP-COOD (PP (TO to) (NP (JJ adrenal) (NN cortisol) (NN suppression))) (CC and) (PP (RB not) (TO to) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (NN GcR)) (PP (IN of) (NP (NN target) (NNS cells)))))))))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN process)) (PP (IN of) (NP (NN GcR) (NN regulation))) (PP (IN in) (NP (NN hMNL)))) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ complex) (NN phenomenon)) (VP (VBG awaiting) (NP (RBR further) (NN elucidation))))))))) (. .))
